For each subject, 10 parameters were considered to be the most influential at characterizing the risk of occurrence of these types of chromosomal anomalies.
The database was composed of 31611 cases of pregnant women. 31135 women did not show any chromosomal abnor malities, while the remaining 476 were confirmed as having a chromosomal anomaly ofT21, T18, T13, or Turner Syndrome.
From the total of 31611 cases, 8191 were kept as a totally unknown database that was only used for the verification of the predictability of the network. In this set, 7 were of the Turner syndrome, 14 of the Patau syndrome, 42 of the Edwards syn drome and 71 of the Down syndrome.
For each subject, 10 parameters were considered to be the most influential at characterizing the risk of occurrence of these types of chromosomal anomalies.
The best results were obtained when using a multi-layer neu ral structure having an input, an output and three hidden lay ers. For the case of the totally unknown verification set of the 8191 cases, 98.1 % were correctly identified. The percentage of abnormal cases correctly predicted was 85.1 %. The unknown T21 cases were predicted by 78.9%, the T18 by 76.2%, the T13 by 0.0% and the Turner syndrome by 42.9%. In addition, trisomy 13 and Turner's syndrome, unlike trisomies 21 and 18, are associated with fetal tachycardia.
I. INTRODUCTION
There is also an association between aneuploidies and cer tain fetal anatomical abnormalities detectable at the first trimester scan, including holoprosencephaly, cardiac defects, diaphragmatic hernia and exomphalos. The neural structures that were attempted were mainly of the feedforward class, both of standard multi-layer type, as well as multi-slab topologies.
Once acceptably reliable results are obtained through the examination of a large number of ANN structures and neu ron parameters, an automatic and user friendly tool can be built. Such a tool may improve the detection of chromoso mal defects, and be a user-friendly and reliable predictor or method for the effective and early identification of an ab normality. The tool would be of great help to obstetricians and of course to pregnant women and the unborn children.
In recent years, ANNs and other computationally intelli gent techniques have been used as medical diagnosis tools, aiming at achieving effective medical decisions that could be incorporated in appropriate medical support systems, for diagnosis, in signal processing/analysis, and in medical im age analysis and radiology [1] - [3] . Neural networks in par ticular have proved to be quite effective and also have re sulted in some relevant patents [4] - [8] .
II. DATA AND METHODS
The database that was used for the training and evaluation For each case, a total of 16 parameters were identified and measured or recorded. However, because some data were redundant, and also because there were very few cases of pregnant women exhibiting some of the parameters (mainly on whether there were previous occurrences of the chromo somal anomalies), these were excluded in the study, and ultimately only 10 parameters were considered to be the most influential at characterizing the risk of occurrence of chromosomal anomalies.
The 10 parameters used for the network training are shown in Table 1 , where the explanation for each of the characteristics has been given in previous paragraphs. A guidance set of 109 cases was extracted and used to test the progress of training at the end of each epoch. Thus it was not directly being used for the training of the network. It was rather a testing paradigm that was mainly used for helping the system to always keep (save) the best performing synap tic weight distribution. This guidance data set included 40
cases (45%) of fetuses that were chromosomally abnormal.
Also, out of the total of 31611 cases, a data set having 8191 (25.9%) cases of pregnant women was kept as a totally un known database that was used for the verification of the pre dictability of each of the attempted neural network. Thus these cases were never given to the network during the train ing period. They were totally unknown to the best selected neural structure, and thus they were a reliable way for ascer taining the predictability of the network. In this set, 7
(0.08%) cases were of the Turner syndrome, 14 (0.17%) of the Patau syndrome, 42 (0.51 %) of the Edwards syndrome and 71 (0.85%) of the Down syndrome.
Thus, the data set is highly unbalanced, and consequently very difficult to study. The nature of this problem makes the use of artificial neural networks more interesting since their ability to handle such complex problems can be demon strated.
III. THE NEURAL CLASSIFIER/PREDICTOR
A number of feedforward neural structures, both of stan dard multilayer type, of varying number of layers and neu rons per layer, as well as multi-slab of different structures, sizes, and activation functions, were systematically built, trained and verified in order to find the best performing for the prediction of the totally unknown data set. This was done in a planned and systematic manner so that the best performing architecture would be obtained.
After numerous trials, it was ultimately possible to select and use a feedforward multilayer neural structure having five layers. The particulars of the neural structure are de picted in Figure 1 . The training progress was monitored in order to observe whether there was improvement during the application of the training and test set data. For most of the network struc tures attempted, there was little generalization improvement after about 1500 epochs. Different sets of inputs -among the 10 available parame ters -were used to find an effective neural structure that would screen for chromosomal defects to an acceptable level. The inputs that were ultimately selected are those shown in Table 1 .
IV. RESULTS AND CONCLUSIONS
The results on the performance of the neural network for the totally unknown verification set of 8191 cases are sum marized in Table 2 .
In Tables 2 and 3 , the sensitivity and specificity quoted are those that were obtained by the following expressions: The results on the performance of the neural network for the totally unknown verification set for each separate class of chromosomal abnormality are summarized in Table 3 .
The results shown in Tables 2 and 3 are very encouraging, because they give a high screening/diagnostic yield for the totally unknown data set. This is particularly true for the Down syndrome.
For the other syndromes the diagnostic yield is low, but this is mainly due to the fact that the number of abnormal chromosomal cases of pregnant women in the data sets is small. This of course is fortunate, and there is no way to generate artificial data for such serious genetic anomalies.
Experiments are currently being done to screen separately for each anomaly through dedicated networks. The results so far are encouraging. These will be reported in future work.
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